Lockheed Martin: Dividend Appeal Versus Institutional Doubt
Published on 12/01/2025 at 05:02 | Redaktion boerse-global.de
Lockheed Martin shares face a pivotal session this Monday, presenting investors with a compelling dichotomy. As the stock trades ex-dividend, offering a substantial quarterly payout, significant institutional investors are concurrently reducing their stakes. This divergence raises a critical question about whether the stock's yield can offset the growing caution among professional money managers.
Trading commenced on Monday, December 1st, with Lockheed Martin shares marked ex-dividend. Shareholders of record are set to receive a quarterly distribution of $3.45 per share on December 30th. Annualized, this payout equates to an approximate yield of 3% at recent price levels.
Beneath this attractive income proposition, however, notable shifts in institutional ownership are occurring. Recent regulatory filings reveal a trend of divestment. The New York State Common Retirement Fund decreased its holding by 2.1% in the second quarter, selling 5,200 shares. A more substantial reduction was executed by Scotia Capital, which slashed its position by a significant 22.1%. These moves are contrasted by Mackenzie Financial, which increased its stake by 3%. This mixed activity underscores the deep division over the equity's valuation in the $450 to $460 range.
Robust Earnings Met with Tepid Guidance
The hesitation from major funds appears rooted in a fundamental disconnect within the company's recent communications. Lockheed Martin posted a strong third-quarter performance, with earnings per share reaching $6.95, surpassing the average analyst estimate of $6.33. Revenue also saw healthy growth, climbing 8.8% to $18.61 billion.
Should investors sell immediately? Or is it worth buying Lockheed?
The concern stems from management's subsequent outlook. For the full 2025 fiscal year, the company issued EPS guidance between $22.15 and $22.35. This forecast falls notably short of the consensus analyst expectation, which stands around $27.15. This gap between present operational success and a conservative future projection is fueling market uncertainty. The analyst community reflects this ambivalence: of 25 firms covering the stock, 15 currently maintain a "Hold" rating, while only seven advocate a "Buy."
Sector Tailwinds and Divergent Price Targets
This caution persists even within a favorable industry context. Global defense contractors collectively achieved record sales last year, with revenues advancing 5.9%. Some market researchers see the current valuation as an opportunity amidst the doubt. BNP Paribas Exane has assigned an "Outperform" rating with a price target of $550, anticipating a substantial rebound. The average price target among analysts is $515.50, representing a potential 12% upside from Friday's closing price.
The core investment dilemma remains unresolved. Is the reliable dividend sufficient to anchor the investment thesis, or does the subdued corporate guidance represent a red flag that institutional investors are heeding?
Ad
Lockheed Stock: Buy or Sell?! New Lockheed Analysis from December 1 delivers the answer:
The latest Lockheed figures speak for themselves: Urgent action needed for Lockheed investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 1.
Lockheed: Buy or sell? Read more here...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
